Aspects of fetal physiology from 18 to 37 weeks' gestation as assessed by blood sampling

Simona Nava, Luisa Bocconi, Guglielmo Zuliani, Alessandra Kustermann, Umberto Nicolini

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Objective: To construct reference ranges for fetal pH, oxygen pressure (PO2), and hematologic and biochemical blood constituents, which can be used to analyze changes with gestation and differences with maternal values, thus elucidating some aspects of fetal biology and the effects of the maternal and placental environments. Methods: We assayed venous pH, PO2 hematocrit, glucose, uric acid, urea, creatinine, total protein, total and direct bilirubin, aspartate aminotransferase, alanine aminotransferase, γ-glutamyl transferase, alkaline phosphatase, lactic dehydrogenase, amylase, pseudocholinesterase, creatine kinase, triglycerides, and cholesterol concentrations in 157 fetuses and 134 mothers who underwent fetal blood sampling from 18 to 37 weeks' gestation. None of the fetuses was infected or had chromosomal, hematologic, or hormonal abnormalities. Results: All the variables analyzed were similar in fetuses sampled at the placental cord insertion (n = 125) or at the intrahepatic vein (n = 32). Maternal and fetal concentrations of glucose (r = 0.79, P <.001), urea (r = 0.96, P <.001), creatinine (r = 0.83, P <.001), and uric acid (r = 0.94, P <.001) correlated significantly, and their differences exhibited significant changes: the maternal-fetal differences of glucose and urea increased, whereas those of uric acid and creatinine decreased with advancing gestation. Fetal pH and PO2 decreased with gestational age, whereas hematocrit increased, similar to what has been described previously. All of the other variables, with the exception of amylase and cholesterol, changed significantly during the investigated period of pregnancy. Gestational age explained at least 40% of the variance in values of fetal total protein, pseudocholinesterase, alanine aminotransferase, creatine kinase, and triglycerides, but only 3-25% of the variation in the remainder. Most enzymes were higher in the fetus than in the maternal circulation, and all except alkaline phosphatase increased with gestational age. The maternal-fetal glucose difference correlated significantly with hematocrit, pH, and PO2, independent of gestational age and independent of each other. Conclusion: With the exception of aspartate aminotransferase, all of the analyzed fetal variables were different from the maternal values, and most changed with gestational age. The mechanisms leading to these fetal specificities remain mostly uncertain, but the provision of reference ranges for several blood constituents may be useful in the differential diagnosis of fetal disease.

Original languageEnglish
Pages (from-to)975-980
Number of pages6
JournalObstetrics and Gynecology
Volume87
Issue number6
DOIs
Publication statusPublished - Jun 1996

Fingerprint

Mothers
Gestational Age
Pregnancy
Fetus
Uric Acid
Hematocrit
Pseudocholinesterase
Urea
Glucose
Creatinine
Amylases
Creatine Kinase
Aspartate Aminotransferases
Alanine Transaminase
Alkaline Phosphatase
Reference Values
Triglycerides
Cholesterol
Fetal Proteins
Fetal Diseases

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Aspects of fetal physiology from 18 to 37 weeks' gestation as assessed by blood sampling. / Nava, Simona; Bocconi, Luisa; Zuliani, Guglielmo; Kustermann, Alessandra; Nicolini, Umberto.

In: Obstetrics and Gynecology, Vol. 87, No. 6, 06.1996, p. 975-980.

Research output: Contribution to journalArticle

Nava, Simona ; Bocconi, Luisa ; Zuliani, Guglielmo ; Kustermann, Alessandra ; Nicolini, Umberto. / Aspects of fetal physiology from 18 to 37 weeks' gestation as assessed by blood sampling. In: Obstetrics and Gynecology. 1996 ; Vol. 87, No. 6. pp. 975-980.
@article{570742face55442db80b60c059c9f491,
title = "Aspects of fetal physiology from 18 to 37 weeks' gestation as assessed by blood sampling",
abstract = "Objective: To construct reference ranges for fetal pH, oxygen pressure (PO2), and hematologic and biochemical blood constituents, which can be used to analyze changes with gestation and differences with maternal values, thus elucidating some aspects of fetal biology and the effects of the maternal and placental environments. Methods: We assayed venous pH, PO2 hematocrit, glucose, uric acid, urea, creatinine, total protein, total and direct bilirubin, aspartate aminotransferase, alanine aminotransferase, γ-glutamyl transferase, alkaline phosphatase, lactic dehydrogenase, amylase, pseudocholinesterase, creatine kinase, triglycerides, and cholesterol concentrations in 157 fetuses and 134 mothers who underwent fetal blood sampling from 18 to 37 weeks' gestation. None of the fetuses was infected or had chromosomal, hematologic, or hormonal abnormalities. Results: All the variables analyzed were similar in fetuses sampled at the placental cord insertion (n = 125) or at the intrahepatic vein (n = 32). Maternal and fetal concentrations of glucose (r = 0.79, P <.001), urea (r = 0.96, P <.001), creatinine (r = 0.83, P <.001), and uric acid (r = 0.94, P <.001) correlated significantly, and their differences exhibited significant changes: the maternal-fetal differences of glucose and urea increased, whereas those of uric acid and creatinine decreased with advancing gestation. Fetal pH and PO2 decreased with gestational age, whereas hematocrit increased, similar to what has been described previously. All of the other variables, with the exception of amylase and cholesterol, changed significantly during the investigated period of pregnancy. Gestational age explained at least 40{\%} of the variance in values of fetal total protein, pseudocholinesterase, alanine aminotransferase, creatine kinase, and triglycerides, but only 3-25{\%} of the variation in the remainder. Most enzymes were higher in the fetus than in the maternal circulation, and all except alkaline phosphatase increased with gestational age. The maternal-fetal glucose difference correlated significantly with hematocrit, pH, and PO2, independent of gestational age and independent of each other. Conclusion: With the exception of aspartate aminotransferase, all of the analyzed fetal variables were different from the maternal values, and most changed with gestational age. The mechanisms leading to these fetal specificities remain mostly uncertain, but the provision of reference ranges for several blood constituents may be useful in the differential diagnosis of fetal disease.",
author = "Simona Nava and Luisa Bocconi and Guglielmo Zuliani and Alessandra Kustermann and Umberto Nicolini",
year = "1996",
month = "6",
doi = "10.1016/0029-7844(96)00056-7",
language = "English",
volume = "87",
pages = "975--980",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Aspects of fetal physiology from 18 to 37 weeks' gestation as assessed by blood sampling

AU - Nava, Simona

AU - Bocconi, Luisa

AU - Zuliani, Guglielmo

AU - Kustermann, Alessandra

AU - Nicolini, Umberto

PY - 1996/6

Y1 - 1996/6

N2 - Objective: To construct reference ranges for fetal pH, oxygen pressure (PO2), and hematologic and biochemical blood constituents, which can be used to analyze changes with gestation and differences with maternal values, thus elucidating some aspects of fetal biology and the effects of the maternal and placental environments. Methods: We assayed venous pH, PO2 hematocrit, glucose, uric acid, urea, creatinine, total protein, total and direct bilirubin, aspartate aminotransferase, alanine aminotransferase, γ-glutamyl transferase, alkaline phosphatase, lactic dehydrogenase, amylase, pseudocholinesterase, creatine kinase, triglycerides, and cholesterol concentrations in 157 fetuses and 134 mothers who underwent fetal blood sampling from 18 to 37 weeks' gestation. None of the fetuses was infected or had chromosomal, hematologic, or hormonal abnormalities. Results: All the variables analyzed were similar in fetuses sampled at the placental cord insertion (n = 125) or at the intrahepatic vein (n = 32). Maternal and fetal concentrations of glucose (r = 0.79, P <.001), urea (r = 0.96, P <.001), creatinine (r = 0.83, P <.001), and uric acid (r = 0.94, P <.001) correlated significantly, and their differences exhibited significant changes: the maternal-fetal differences of glucose and urea increased, whereas those of uric acid and creatinine decreased with advancing gestation. Fetal pH and PO2 decreased with gestational age, whereas hematocrit increased, similar to what has been described previously. All of the other variables, with the exception of amylase and cholesterol, changed significantly during the investigated period of pregnancy. Gestational age explained at least 40% of the variance in values of fetal total protein, pseudocholinesterase, alanine aminotransferase, creatine kinase, and triglycerides, but only 3-25% of the variation in the remainder. Most enzymes were higher in the fetus than in the maternal circulation, and all except alkaline phosphatase increased with gestational age. The maternal-fetal glucose difference correlated significantly with hematocrit, pH, and PO2, independent of gestational age and independent of each other. Conclusion: With the exception of aspartate aminotransferase, all of the analyzed fetal variables were different from the maternal values, and most changed with gestational age. The mechanisms leading to these fetal specificities remain mostly uncertain, but the provision of reference ranges for several blood constituents may be useful in the differential diagnosis of fetal disease.

AB - Objective: To construct reference ranges for fetal pH, oxygen pressure (PO2), and hematologic and biochemical blood constituents, which can be used to analyze changes with gestation and differences with maternal values, thus elucidating some aspects of fetal biology and the effects of the maternal and placental environments. Methods: We assayed venous pH, PO2 hematocrit, glucose, uric acid, urea, creatinine, total protein, total and direct bilirubin, aspartate aminotransferase, alanine aminotransferase, γ-glutamyl transferase, alkaline phosphatase, lactic dehydrogenase, amylase, pseudocholinesterase, creatine kinase, triglycerides, and cholesterol concentrations in 157 fetuses and 134 mothers who underwent fetal blood sampling from 18 to 37 weeks' gestation. None of the fetuses was infected or had chromosomal, hematologic, or hormonal abnormalities. Results: All the variables analyzed were similar in fetuses sampled at the placental cord insertion (n = 125) or at the intrahepatic vein (n = 32). Maternal and fetal concentrations of glucose (r = 0.79, P <.001), urea (r = 0.96, P <.001), creatinine (r = 0.83, P <.001), and uric acid (r = 0.94, P <.001) correlated significantly, and their differences exhibited significant changes: the maternal-fetal differences of glucose and urea increased, whereas those of uric acid and creatinine decreased with advancing gestation. Fetal pH and PO2 decreased with gestational age, whereas hematocrit increased, similar to what has been described previously. All of the other variables, with the exception of amylase and cholesterol, changed significantly during the investigated period of pregnancy. Gestational age explained at least 40% of the variance in values of fetal total protein, pseudocholinesterase, alanine aminotransferase, creatine kinase, and triglycerides, but only 3-25% of the variation in the remainder. Most enzymes were higher in the fetus than in the maternal circulation, and all except alkaline phosphatase increased with gestational age. The maternal-fetal glucose difference correlated significantly with hematocrit, pH, and PO2, independent of gestational age and independent of each other. Conclusion: With the exception of aspartate aminotransferase, all of the analyzed fetal variables were different from the maternal values, and most changed with gestational age. The mechanisms leading to these fetal specificities remain mostly uncertain, but the provision of reference ranges for several blood constituents may be useful in the differential diagnosis of fetal disease.

UR - http://www.scopus.com/inward/record.url?scp=0029895324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029895324&partnerID=8YFLogxK

U2 - 10.1016/0029-7844(96)00056-7

DO - 10.1016/0029-7844(96)00056-7

M3 - Article

C2 - 8649709

AN - SCOPUS:0029895324

VL - 87

SP - 975

EP - 980

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 6

ER -